HDL and type 2 diabetes: the chicken or the egg?

E Xepapadaki, I Nikdima, EC Sagiadinou, E Zvintzou… - Diabetologia, 2021 - Springer
HDL is a complex macromolecular cluster of various components, such as apolipoproteins,
enzymes and lipids. Quality evidence from clinical and epidemiological studies led to the …

[PDF][PDF] Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

WJ Shen, S Asthana, FB Kraemer, S Azhar - Journal of lipid research, 2018 - academia.edu
Cholesterol is required for maintenance of plasma membrane fluidity and integrity and for
many cellular functions. Cellular cholesterol can be obtained from lipoproteins in a selective …

Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer

Y Xiong, Y Zhao, L Miao, CM Lin, L Huang - Journal of Controlled Release, 2016 - Elsevier
Clinically, combined therapy of cisplatin (CDDP) and metformin is an effective treatment for
non-small cell lung cancer (NSCLC). The success is attributed to synergistic effects between …

Recent insights into the pathogenesis of acute porphyria attacks and increasing hepatic PBGD as an etiological treatment

D Jericó, KM Córdoba, A Sampedro, L Jiang, G Joucla… - Life, 2022 - mdpi.com
Rare diseases, especially monogenic diseases, which usually affect a single target protein,
have attracted growing interest in drug research by encouraging pharmaceutical companies …

Propranolol exhibits activity against hemangiomas independent of beta blockade

M Sasaki, PE North, J Elsey, J Bubley, S Rao… - NPJ precision …, 2019 - nature.com
Propranolol is a widely used beta blocker that consists of a racemic mixture of R and S
stereoisomers. Only the S stereoisomer has significant activity against the beta-adrenergic …

Understanding carbohydrate metabolism and insulin resistance in acute intermittent porphyria

I Solares, D Jericó, KM Córdoba… - International journal of …, 2022 - mdpi.com
Porphobilinogen deaminase (PBGD) haploinsufficiency (acute intermittent porphyria, AIP) is
characterized by neurovisceral attacks associated with high production, accumulation and …

Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases

L Xiang, Y Shao, Y Chen - Journal of Drug Targeting, 2021 - Taylor & Francis
The liver is a vital metabolic and detoxifying organ and suffers diverse endogenous or
exogenous damage. Hepatocyte mitochondria experience various structural and functional …

[HTML][HTML] Advances in high-density lipoprotein physiology: surprises, overturns, and promises

C Constantinou, EA Karavia… - American Journal …, 2016 - journals.physiology.org
Emerging evidence strongly supports that changes in the HDL metabolic pathway, which
result in changes in HDL proteome and function, appear to have a causative impact on a …

Metformin protects high glucose-cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK …

XD Liu, YG Li, GY Wang, YG Bi… - Molecular …, 2020 - spandidos-publications.com
Tissue damage in diabetes is at least partly due to elevated reactive oxygen species
production by the mitochondrial respiratory chain during hyperglycemia. Sustained …

High prevalence of insulin resistance in asymptomatic patients with acute intermittent porphyria and liver-targeted insulin as a novel therapeutic approach

I Solares, L Izquierdo-Sánchez, M Morales-Conejo… - Biomedicines, 2021 - mdpi.com
Acute porphyria attacks are associated with the strong up-regulation of hepatic heme
synthesis and over-production of neurotoxic heme precursors. First-line therapy is based on …